Bariatric surgery to treat type 2 diabetes: What is the recent evidence?

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 5, 2012, Pages 352-358

  Van Gaal, Luc F ^a   De Block, Christophe E M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

bariatric surgery; body mass index; diabetes; gastric bypass; remission of diabetes

Indexed keywords

HEMOGLOBIN A1C;

BARIATRIC SURGERY; BILE ACID METABOLISM; BILIOPANCREATIC BYPASS; BLOOD PRESSURE; BODY MASS; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DYSLIPIDEMIA; GASTRIC BANDING; GASTROINTESTINAL TRANSIT; GASTROPLASTY; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LONG TERM CARE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SLEEVE GASTRECTOMY; STOMACH BYPASS; STOMACH EMPTYING; SURGICAL INFECTION; WEIGHT REDUCTION;

BARIATRIC SURGERY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; OBESITY, MORBID; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; REMISSION INDUCTION; WEIGHT LOSS;

EID: 84865956943     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328357f0e0     Document Type: Review

References (35)

1. IDF diabetes atlas. 5th ed. Brussels: International Diabetes Federation; 2011. http://www.idf.org/diabetesatlas.
2. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444:875-880.
3. Saydeh SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291:335-342.
4. Redmon JB, Bertoni AG, Connelly S, et al. Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care 2010; 33:1153-1158.
5. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord 1997; 21 (Suppl. 1):S5-S9.
6. Mertens IL, Van Gaal LF. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res 2000; 8:270-278.
7. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248.e5-256.e5.
8. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-1737.
9. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009; CD003641.
10. Dixon JB, Zimmet P, Alberti KG, Rubino F; on behalf of the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabet Med 2011; 28:628-642.
11. Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes Obes Metab 2012; 14:262-270.
12. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222:339-352.
13. National Institutes of Health. Gastrointestinal surgery for sever obesity: National Institutes of Health consensus conference statement. Am J Clin Nutr 1992; 55:615-619.
14. Purnell JQ, Flum DR. Bariatric surgery and diabetes. Who should be offered the option of remission? JAMA 2009; 301:1592-1595.
15. Mechanick JI, Kushner RF, Sugerman HJ, et al., American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008; 14:S1-S83.
16. Sjöström L, Lindroos AK, Peltonen M, et al., Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-2693.
17. Sjöström L, Narbro K, Sjöström CD, et al., Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741-752.
18. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357:753-761.
19. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150:2518-2525.
20. Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96:E1372-E1379.
21. Chiellini C, Rubino F, Castagneto M, et al. The effect of bilio-pancreatic diversion on type 2 diabetes with BMI <35 kg/m2. Diabetologia 2009; 52:1027-1030.
22. Dirksen C, Jørgensen NB, Bojsen-Møller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012; 50: 1890-1901.
23. Laferrère B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 2011; 35 (Suppl. 3):S22-S25.
24. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35:518-523.
25. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316-323.
26. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:1567-1576.
27. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585.
28. Ryan DH. BMI guidelines for bariatric surgery in diabetes: how low can we go? Diabetes Care 2012; 35:1399-1400.
29. Boza C, Muñoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in nonseverely obese patients. Obes Surg 2011; 21:1330-1336.
30. Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2. Surgery 2011; 150:684-691.
31. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35:1420-1428.
32. Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg 2010; 20:776-790.
33. Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis 2010; 6:332-338.
34. Chang SH, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas 2011; 69:230-238.
35. Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit Consensus Conference recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251:399-405.